NDC 0703-4636

Zanosar

Streptozocin

Zanosar is a Intravenous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Streptozocin.

• Product ID: 0703-4636_a385f86b-b920-40b9-a988-f5340c1c1ff4
• NDC: 0703-4636
• Product Type: Human Prescription Drug
• Proprietary Name: Zanosar
• Generic Name: Streptozocin
• Dosage Form: Powder, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2003-12-03
• Marketing Category: NDA / NDA
• Application Number: NDA050577
• Labeler Name: Teva Parenteral Medicines, Inc.
• Substance Name: STREPTOZOCIN
• Active Ingredient Strength: 100 mg/mL
• Pharm Classes: Alkylating Activity [MoA], Alkylating Drug [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0703-4636-01

10 mL in 1 VIAL (0703-4636-01)

• Marketing Start Date: 2003-12-03
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0703-4636-01 [00703463601]

Zanosar POWDER, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA050577
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-12-03

Drug Details

Active Ingredients

Ingredient	Strength
STREPTOZOCIN	100 mg/mL

OpenFDA Data

• SPL SET ID: 15d161ed-9e7b-4c92-ba45-0556d2423e67
• Manufacturer:
  • Teva Parenteral Medicines, Inc.
• UNII:
  • 5W494URQ81
• RxNorm Concept Unique ID - RxCUI:
  • 207948
  • 239180

Pharmacological Class

• Alkylating Activity [MoA]
• Alkylating Drug [EPC]
• Alkylating Activity [MoA]
• Alkylating Drug [EPC]